| Literature DB >> 27900526 |
Yuli R Tak1, Steven M Brunwasser2, Anna Lichtwarck-Aschoff3, Rutger C M E Engels4,5.
Abstract
Over the course of adolescence, an increasing number of adolescents experience depression. In order to effectively target depression, identifying risk factors for depressive symptoms is pivotal. Since low levels of self-efficacy were associated with higher levels of depressive symptoms in previous studies, the current study investigated the bidirectional and prospective associations between depressive symptoms and academic, social and emotional self-efficacy from early to mid adolescence in a cross-lagged path model. The sample consisted of 1,341 adolescents (47 % girls) with a mean age of 14 years, SD = 0.56. Depressive symptoms and self-efficacy levels were assessed every 6 months over a period of 2.5 years. Depressive symptoms predicted subsequent levels of academic and emotional self-efficacy on all time points, and social self-efficacy on one time point. Self-efficacy did not predict subsequent levels of depressive symptoms. There was no evidence of sex differences in the cross-lagged associations between depressive symptoms and self-efficacy levels. Implications of the findings are discussed.Entities:
Keywords: Adolescence; Depressive symptoms; Self-efficacy
Mesh:
Year: 2016 PMID: 27900526 PMCID: PMC5346145 DOI: 10.1007/s10964-016-0614-z
Source DB: PubMed Journal: J Youth Adolesc ISSN: 0047-2891
Means and standard deviations of depressive symptoms, academic, social, and emotional self-efficacy
| Variable |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DS1 | 7.55 (5.70) | – | ||||||||||||||||||||
| 2 | ASE1 | 24.53 (5.27) | −.55 | – | |||||||||||||||||||
| 3 | SSE1 | 26.36 (4.32) | −.40 | .26 | – | ||||||||||||||||||
| 4 | ESE1 | 24.08 (5.18) | −.57 | .35 | .56 | – | |||||||||||||||||
| 5 | DS2 | 8.06 (6.59) | .59 | −.38 | −.23 | −.35 | – | ||||||||||||||||
| 6 | ASE2 | 24.82 (5.53) | −.38 | .57 | .12 | .22 | −.50 | – | |||||||||||||||
| 7 | SSE2 | 26.12 (5.08) | −.28 | .17 | .47 | .31 | −.42 | .55 | – | ||||||||||||||
| 8 | ESE2 | 24.60 (5.35) | −.37 | .20 | .30 | .51 | −.50 | .59 | .72 | – | |||||||||||||
| 9 | DS3 | 7.70 (6.33) | .53 | −.35 | −.28 | −.33 | .55 | −.37 | −.29 | −.34 | – | ||||||||||||
| 10 | ASE3 | 24.29 (5.33) | −.35 | .52 | .14 | .21 | −.37 | .54 | .25 | .29 | .51 | – | |||||||||||
| 11 | SSE3 | 26.03 (4.99) | −.27 | .18 | .47 | .28 | −.26 | .25 | .48 | .34 | −.43 | .52 | – | ||||||||||
| 12 | ESE3 | 24.60 (5.17) | −.34 | .20 | .30 | .46 | −.35 | .29 | .35 | .52 | −.49 | .56 | .72 | – | |||||||||
| 13 | DS4 | 8.56 (8.18) | .35 | −.27 | −.18 | −.24 | .37 | −.26 | −.21 | −.24 | .57 | −.37 | −.31 | −.34 | – | ||||||||
| 14 | ASE4 | 23.73 (5.73) | −.23 | .39 | .11 | .12 | −.29 | .40 | .19 | .19 | −.42 | .56 | .25 | .25 | −.48 | – | |||||||
| 15 | SSE4 | 25.06 (5.62 | −.19 | .16 | .32 | .17 | −.23 | .18 | .33 | .21 | −.35 | .26 | .44 | .30 | −.46 | .65 | – | ||||||
| 16 | ESE4 | 23.84 (5.62) | −.22 | .16 | .24 | .33 | −.30 | .22 | .28 | .36 | −.39 | .30 | .36 | .47 | −.48 | .68 | .80 | – | |||||
| 17 | DS5 | 8.63 (8.15) | .37 | −.29 | −.20 | −.23 | .40 | −.27 | −.21 | −.22 | .47 | −.36 | −.27 | −.30 | .57 | −.40 | −.38 | −.41 | – | ||||
| 18 | ASE5 | 23.59 (5.44) | −.28 | .44 | .08 | .15 | −.29 | .42 | .14 | .16 | −.36 | .54 | .22 | .22 | −.36 | .51 | .27 | .29 | −.52 | – | |||
| 19 | SSE5 | 25.45 (5.09) | −.22 | .21 | .34 | .20 | −.22 | .18 | .32 | .19 | −.30 | .25 | .46 | .27 | −.32 | .26 | .46 | .35 | −.50 | .56 | – | ||
| 20 | ESE5 | 23.87 (5.26) | −.27 | .23 | .20 | .35 | −.28 | .21 | .23 | .34 | −.32 | .28 | .31 | .45 | −.37 | .27 | .32 | .47 | −.54 | .57 | .72 | – | |
| 21 | DS6 | 8.18 (7.44) | .39 | −.29 | −.19 | −.26 | .38 | −.27 | −.24 | −.27 | .50 | −.33 | −.31 | −.35 | .49 | −.37 | −.33 | −.38 | .61 | −.39 | −.35 | −.38 | – |
DS1 DS6 depressive symptoms time one—time six, ASE1 ASE5 academic self-efficacy time one–time 5, SSE1 SSE5 social self-efficacy time one—time five, ESE1 ESE5 emotional self-efficacy time one—time five
All correlations were significant at the p < .01 level
Fig. 1Cross-lagged model of depressive symptoms, academic, social and emotional self-efficacy (N = 1,341, standardized estimates). DS depressive symptoms, ASE academic self-efficacy, SSE social self-efficacy, ESE emotional self-efficacy. All other parameter estimates are presented in Appendix: the stability across time and the cross-lagged associations between SE domains, and the concurrent correlations. *p < 0.05; **p < 0.01; ***p < 0.001
Final model: Cross-lagged associations, stability estimates and concurrent correlations of depressive symptoms, academic, social, and emotional self-efficacy
| T2 ← T1 | T3 ← T2 | T4 ← T3 | T5 ← T4 | ||
|---|---|---|---|---|---|
| Cross-lagged associations | |||||
| ASE ← SSE (f) | −.023 | −.029 | −.025 | −.031 | |
| ASE ← ESE (f) | .005 | .006 | .005 | .006 | |
| SSE ← ESE (f) | .066 | .074 | .064 | .067 | |
| SSE ← ASE (f) | −.003 | −.004 | −.003 | −.004 | |
| ESE ← ASE (f) | −.019 | −.022 | −.018 | −.022 | |
| ESE ← SSE (f) | −.010 | −.013 | −.011 | −.013 | |
| Stability estimates | |||||
| ASE ← ASE (f) | .137*** | .157*** | .138*** | .159*** | |
| SSE ← SSE (f) | .091** | .113*** | .093** | .119** | |
| ESE ← ESE (f) | .128*** | .143*** | .121*** | .146*** | |
| Concurrent correlations | T1 | T2 | T3 | T4 | T5 |
| DS—ASE | −.492*** | −.327*** | −.287*** | −.300*** | −.354*** |
| DS—SSE | −.357*** | −.319*** | −.275*** | −.328*** | −.377*** |
| DS—ESE | −.527*** | −.344*** | −.292*** | −.307*** | −.396*** |
| ASE—SSE | .267*** | .647*** | .571*** | .737*** | .604*** |
| ASE—ESE | .256*** | .526*** | .375*** | .634*** | .470*** |
| SSE—ESE | .354*** | .664*** | .591*** | .774*** | .605*** |
DS depressive symptoms, ASE academic self-efficacy, SSE social self-efficacy, ESE emotional self-efficacy, f fixed
*p < 0.05; **p < 0.01; ***p < 0.001